Incannex Healthcare: Expects record sales in June quarter
- Incannex Healthcare (IHL), formerly known as Impression Healthcare, expects to report $671,000 in cash sales receipts for the June 2020 quarter
- This represents a 97 per cent increase on the June 2019 quarter
- It also marks the largest quarter in sales since the company first listed on the ASX in November 2016
- Incannex develops a range of medicinal cannabis products and the best seller has been Cannagesia
- On June 30, 2500 units of Cannagesis were received and sales momentum is expected to continue
- Then the company shares are up 6.12 per cent and are trading for 5.2 cents each